| 发明名称 |
METHOD OF IMPROVING COGNITION AND SOCIAL BEHAVIOR IN HUMANS HAVING DEFICITS THEREIN DUE TO NEURODEGENERATIVE DISORDERS AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 摘要 |
A β1-ADR agonist prodrug compound, which is hydrolysable in vivo to release a β1-ADR agonist compound, and which prodrug compound contains a group which imparts greater lipophilicity and CNS bioavailability to the prodrug compound relative to the β1-ADR agonist compound. |
| 申请公布号 |
US2016184315(A1) |
申请公布日期 |
2016.06.30 |
| 申请号 |
US201514625170 |
申请日期 |
2015.02.18 |
| 申请人 |
Shamloo Mehrdad;Yi Bitna;Ardestani Pooneh Memar |
发明人 |
Shamloo Mehrdad;Yi Bitna;Ardestani Pooneh Memar |
| 分类号 |
A61K31/5375;G01N33/50;A61K47/48;A61K9/00;A61K9/08 |
主分类号 |
A61K31/5375 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1) A β1-ADR agonist prodrug compound, which is hydrolysable in vivo to release a corresponding β1-ADR agonist compound, and which prodrug compound contains at least one group which imparts greater lipophilicity and CNS bioavailability to the prodrug compound relative to the corresponding β1-ADR agonist compound. |
| 地址 |
Palo Alto CA US |
